Global RNA In Situ Hybridization Market Insights, Forecast to 2029

Publisher Name :
Date: 10-Aug-2023
No. of pages: 106
Inquire Before Buying

Market Analysis and Insights: Global RNA In Situ Hybridization Market

The global RNA In Situ Hybridization market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for RNA In Situ Hybridization is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The China market for RNA In Situ Hybridization is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The Europe market for RNA In Situ Hybridization is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global key companies of RNA In Situ Hybridization include Abbott, Biogenex, Biosb, Roche, Sigma-Aldrich, Advanced Cell Diagnostics, Affymetrix, Exiqon and Agilent Technologies, etc. in 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes

This report presents an overview of global market for RNA In Situ Hybridization market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of RNA In Situ Hybridization, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for RNA In Situ Hybridization, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the RNA In Situ Hybridization revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global RNA In Situ Hybridization market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for RNA In Situ Hybridization revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Abbott, Biogenex, Biosb, Roche, Sigma-Aldrich, Advanced Cell Diagnostics, Affymetrix, Exiqon and Agilent Technologies, etc.

By Company

- Abbott

- Biogenex

- Biosb

- Roche

- Sigma-Aldrich

- Advanced Cell Diagnostics

- Affymetrix

- Exiqon

- Agilent Technologies

- Thermo Fisher Scientific

Segment by Type

- GISH

- FISH

- mFISH

- PCR

Segment by Application

- Hospitals

- Pharma & Biotech Companies

- Research Labs

- CROs

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East, Africa, and Latin America

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of RNA In Situ Hybridization in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of RNA In Situ Hybridization companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America by type, by application and by country, revenue for each segment.

Chapter 7: Europe by type, by application and by country, revenue for each segment.

Chapter 8: China by type and by application revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, RNA In Situ Hybridization revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions

Global RNA In Situ Hybridization Market Insights, Forecast to 2029

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNA In Situ Hybridization Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 GISH
1.2.3 FISH
1.2.4 mFISH
1.2.5 PCR
1.3 Market by Application
1.3.1 Global RNA In Situ Hybridization Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Pharma & Biotech Companies
1.3.4 Research Labs
1.3.5 CROs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global RNA In Situ Hybridization Market Perspective (2018-2029)
2.2 Global RNA In Situ Hybridization Growth Trends by Region
2.2.1 RNA In Situ Hybridization Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 RNA In Situ Hybridization Historic Market Size by Region (2018-2023)
2.2.3 RNA In Situ Hybridization Forecasted Market Size by Region (2024-2029)
2.3 RNA In Situ Hybridization Market Dynamics
2.3.1 RNA In Situ Hybridization Industry Trends
2.3.2 RNA In Situ Hybridization Market Drivers
2.3.3 RNA In Situ Hybridization Market Challenges
2.3.4 RNA In Situ Hybridization Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue RNA In Situ Hybridization by Players
3.1.1 Global RNA In Situ Hybridization Revenue by Players (2018-2023)
3.1.2 Global RNA In Situ Hybridization Revenue Market Share by Players (2018-2023)
3.2 Global RNA In Situ Hybridization Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of RNA In Situ Hybridization, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global RNA In Situ Hybridization Market Concentration Ratio
3.4.1 Global RNA In Situ Hybridization Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNA In Situ Hybridization Revenue in 2022
3.5 Global Key Players of RNA In Situ Hybridization Head office and Area Served
3.6 Global Key Players of RNA In Situ Hybridization, Product and Application
3.7 Global Key Players of RNA In Situ Hybridization, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 RNA In Situ Hybridization Breakdown Data by Type
4.1 Global RNA In Situ Hybridization Historic Market Size by Type (2018-2023)
4.2 Global RNA In Situ Hybridization Forecasted Market Size by Type (2024-2029)
5 RNA In Situ Hybridization Breakdown Data by Application
5.1 Global RNA In Situ Hybridization Historic Market Size by Application (2018-2023)
5.2 Global RNA In Situ Hybridization Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America RNA In Situ Hybridization Market Size (2018-2029)
6.2 North America RNA In Situ Hybridization Market Size by Type
6.2.1 North America RNA In Situ Hybridization Market Size by Type (2018-2023)
6.2.2 North America RNA In Situ Hybridization Market Size by Type (2024-2029)
6.2.3 North America RNA In Situ Hybridization Market Share by Type (2018-2029)
6.3 North America RNA In Situ Hybridization Market Size by Application
6.3.1 North America RNA In Situ Hybridization Market Size by Application (2018-2023)
6.3.2 North America RNA In Situ Hybridization Market Size by Application (2024-2029)
6.3.3 North America RNA In Situ Hybridization Market Share by Application (2018-2029)
6.4 North America RNA In Situ Hybridization Market Size by Country
6.4.1 North America RNA In Situ Hybridization Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America RNA In Situ Hybridization Market Size by Country (2018-2023)
6.4.3 North America RNA In Situ Hybridization Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe RNA In Situ Hybridization Market Size (2018-2029)
7.2 Europe RNA In Situ Hybridization Market Size by Type
7.2.1 Europe RNA In Situ Hybridization Market Size by Type (2018-2023)
7.2.2 Europe RNA In Situ Hybridization Market Size by Type (2024-2029)
7.2.3 Europe RNA In Situ Hybridization Market Share by Type (2018-2029)
7.3 Europe RNA In Situ Hybridization Market Size by Application
7.3.1 Europe RNA In Situ Hybridization Market Size by Application (2018-2023)
7.3.2 Europe RNA In Situ Hybridization Market Size by Application (2024-2029)
7.3.3 Europe RNA In Situ Hybridization Market Share by Application (2018-2029)
7.4 Europe RNA In Situ Hybridization Market Size by Country
7.4.1 Europe RNA In Situ Hybridization Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe RNA In Situ Hybridization Market Size by Country (2018-2023)
7.4.3 Europe RNA In Situ Hybridization Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China RNA In Situ Hybridization Market Size (2018-2029)
8.2 China RNA In Situ Hybridization Market Size by Type
8.2.1 China RNA In Situ Hybridization Market Size by Type (2018-2023)
8.2.2 China RNA In Situ Hybridization Market Size by Type (2024-2029)
8.2.3 China RNA In Situ Hybridization Market Share by Type (2018-2029)
8.3 China RNA In Situ Hybridization Market Size by Application
8.3.1 China RNA In Situ Hybridization Market Size by Application (2018-2023)
8.3.2 China RNA In Situ Hybridization Market Size by Application (2024-2029)
8.3.3 China RNA In Situ Hybridization Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia RNA In Situ Hybridization Market Size (2018-2029)
9.2 Asia RNA In Situ Hybridization Market Size by Type
9.2.1 Asia RNA In Situ Hybridization Market Size by Type (2018-2023)
9.2.2 Asia RNA In Situ Hybridization Market Size by Type (2024-2029)
9.2.3 Asia RNA In Situ Hybridization Market Share by Type (2018-2029)
9.3 Asia RNA In Situ Hybridization Market Size by Application
9.3.1 Asia RNA In Situ Hybridization Market Size by Application (2018-2023)
9.3.2 Asia RNA In Situ Hybridization Market Size by Application (2024-2029)
9.3.3 Asia RNA In Situ Hybridization Market Share by Application (2018-2029)
9.4 Asia RNA In Situ Hybridization Market Size by Region
9.4.1 Asia RNA In Situ Hybridization Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia RNA In Situ Hybridization Market Size by Region (2018-2023)
9.4.3 Asia RNA In Situ Hybridization Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America RNA In Situ Hybridization Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America RNA In Situ Hybridization Market Size by Type
10.2.1 Middle East, Africa, and Latin America RNA In Situ Hybridization Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America RNA In Situ Hybridization Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America RNA In Situ Hybridization Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America RNA In Situ Hybridization Market Size by Application
10.3.1 Middle East, Africa, and Latin America RNA In Situ Hybridization Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America RNA In Situ Hybridization Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America RNA In Situ Hybridization Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America RNA In Situ Hybridization Market Size by Country
10.4.1 Middle East, Africa, and Latin America RNA In Situ Hybridization Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America RNA In Situ Hybridization Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America RNA In Situ Hybridization Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott RNA In Situ Hybridization Introduction
11.1.4 Abbott Revenue in RNA In Situ Hybridization Business (2018-2023)
11.1.5 Abbott Recent Developments
11.2 Biogenex
11.2.1 Biogenex Company Details
11.2.2 Biogenex Business Overview
11.2.3 Biogenex RNA In Situ Hybridization Introduction
11.2.4 Biogenex Revenue in RNA In Situ Hybridization Business (2018-2023)
11.2.5 Biogenex Recent Developments
11.3 Biosb
11.3.1 Biosb Company Details
11.3.2 Biosb Business Overview
11.3.3 Biosb RNA In Situ Hybridization Introduction
11.3.4 Biosb Revenue in RNA In Situ Hybridization Business (2018-2023)
11.3.5 Biosb Recent Developments
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche RNA In Situ Hybridization Introduction
11.4.4 Roche Revenue in RNA In Situ Hybridization Business (2018-2023)
11.4.5 Roche Recent Developments
11.5 Sigma-Aldrich
11.5.1 Sigma-Aldrich Company Details
11.5.2 Sigma-Aldrich Business Overview
11.5.3 Sigma-Aldrich RNA In Situ Hybridization Introduction
11.5.4 Sigma-Aldrich Revenue in RNA In Situ Hybridization Business (2018-2023)
11.5.5 Sigma-Aldrich Recent Developments
11.6 Advanced Cell Diagnostics
11.6.1 Advanced Cell Diagnostics Company Details
11.6.2 Advanced Cell Diagnostics Business Overview
11.6.3 Advanced Cell Diagnostics RNA In Situ Hybridization Introduction
11.6.4 Advanced Cell Diagnostics Revenue in RNA In Situ Hybridization Business (2018-2023)
11.6.5 Advanced Cell Diagnostics Recent Developments
11.7 Affymetrix
11.7.1 Affymetrix Company Details
11.7.2 Affymetrix Business Overview
11.7.3 Affymetrix RNA In Situ Hybridization Introduction
11.7.4 Affymetrix Revenue in RNA In Situ Hybridization Business (2018-2023)
11.7.5 Affymetrix Recent Developments
11.8 Exiqon
11.8.1 Exiqon Company Details
11.8.2 Exiqon Business Overview
11.8.3 Exiqon RNA In Situ Hybridization Introduction
11.8.4 Exiqon Revenue in RNA In Situ Hybridization Business (2018-2023)
11.8.5 Exiqon Recent Developments
11.9 Agilent Technologies
11.9.1 Agilent Technologies Company Details
11.9.2 Agilent Technologies Business Overview
11.9.3 Agilent Technologies RNA In Situ Hybridization Introduction
11.9.4 Agilent Technologies Revenue in RNA In Situ Hybridization Business (2018-2023)
11.9.5 Agilent Technologies Recent Developments
11.10 Thermo Fisher Scientific
11.10.1 Thermo Fisher Scientific Company Details
11.10.2 Thermo Fisher Scientific Business Overview
11.10.3 Thermo Fisher Scientific RNA In Situ Hybridization Introduction
11.10.4 Thermo Fisher Scientific Revenue in RNA In Situ Hybridization Business (2018-2023)
11.10.5 Thermo Fisher Scientific Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global RNA In Situ Hybridization Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of GISH
Table 3. Key Players of FISH
Table 4. Key Players of mFISH
Table 5. Key Players of PCR
Table 6. Global RNA In Situ Hybridization Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global RNA In Situ Hybridization Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global RNA In Situ Hybridization Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global RNA In Situ Hybridization Market Share by Region (2018-2023)
Table 10. Global RNA In Situ Hybridization Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global RNA In Situ Hybridization Market Share by Region (2024-2029)
Table 12. RNA In Situ Hybridization Market Trends
Table 13. RNA In Situ Hybridization Market Drivers
Table 14. RNA In Situ Hybridization Market Challenges
Table 15. RNA In Situ Hybridization Market Restraints
Table 16. Global RNA In Situ Hybridization Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global RNA In Situ Hybridization Revenue Share by Players (2018-2023)
Table 18. Global Top RNA In Situ Hybridization by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA In Situ Hybridization as of 2022)
Table 19. Global RNA In Situ Hybridization Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by RNA In Situ Hybridization Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of RNA In Situ Hybridization, Headquarters and Area Served
Table 22. Global Key Players of RNA In Situ Hybridization, Product and Application
Table 23. Global Key Players of RNA In Situ Hybridization, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global RNA In Situ Hybridization Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global RNA In Situ Hybridization Revenue Market Share by Type (2018-2023)
Table 27. Global RNA In Situ Hybridization Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global RNA In Situ Hybridization Revenue Market Share by Type (2024-2029)
Table 29. Global RNA In Situ Hybridization Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global RNA In Situ Hybridization Revenue Share by Application (2018-2023)
Table 31. Global RNA In Situ Hybridization Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global RNA In Situ Hybridization Revenue Share by Application (2024-2029)
Table 33. North America RNA In Situ Hybridization Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America RNA In Situ Hybridization Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America RNA In Situ Hybridization Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America RNA In Situ Hybridization Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America RNA In Situ Hybridization Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America RNA In Situ Hybridization Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America RNA In Situ Hybridization Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe RNA In Situ Hybridization Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe RNA In Situ Hybridization Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe RNA In Situ Hybridization Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe RNA In Situ Hybridization Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe RNA In Situ Hybridization Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe RNA In Situ Hybridization Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe RNA In Situ Hybridization Market Size by Country (2024-2029) & (US$ Million)
Table 47. China RNA In Situ Hybridization Market Size by Type (2018-2023) & (US$ Million)
Table 48. China RNA In Situ Hybridization Market Size by Type (2024-2029) & (US$ Million)
Table 49. China RNA In Situ Hybridization Market Size by Application (2018-2023) & (US$ Million)
Table 50. China RNA In Situ Hybridization Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia RNA In Situ Hybridization Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia RNA In Situ Hybridization Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia RNA In Situ Hybridization Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia RNA In Situ Hybridization Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia RNA In Situ Hybridization Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia RNA In Situ Hybridization Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia RNA In Situ Hybridization Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America RNA In Situ Hybridization Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America RNA In Situ Hybridization Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America RNA In Situ Hybridization Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America RNA In Situ Hybridization Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America RNA In Situ Hybridization Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America RNA In Situ Hybridization Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America RNA In Situ Hybridization Market Size by Country (2024-2029) & (US$ Million)
Table 65. Abbott Company Details
Table 66. Abbott Business Overview
Table 67. Abbott RNA In Situ Hybridization Product
Table 68. Abbott Revenue in RNA In Situ Hybridization Business (2018-2023) & (US$ Million)
Table 69. Abbott Recent Developments
Table 70. Biogenex Company Details
Table 71. Biogenex Business Overview
Table 72. Biogenex RNA In Situ Hybridization Product
Table 73. Biogenex Revenue in RNA In Situ Hybridization Business (2018-2023) & (US$ Million)
Table 74. Biogenex Recent Developments
Table 75. Biosb Company Details
Table 76. Biosb Business Overview
Table 77. Biosb RNA In Situ Hybridization Product
Table 78. Biosb Revenue in RNA In Situ Hybridization Business (2018-2023) & (US$ Million)
Table 79. Biosb Recent Developments
Table 80. Roche Company Details
Table 81. Roche Business Overview
Table 82. Roche RNA In Situ Hybridization Product
Table 83. Roche Revenue in RNA In Situ Hybridization Business (2018-2023) & (US$ Million)
Table 84. Roche Recent Developments
Table 85. Sigma-Aldrich Company Details
Table 86. Sigma-Aldrich Business Overview
Table 87. Sigma-Aldrich RNA In Situ Hybridization Product
Table 88. Sigma-Aldrich Revenue in RNA In Situ Hybridization Business (2018-2023) & (US$ Million)
Table 89. Sigma-Aldrich Recent Developments
Table 90. Advanced Cell Diagnostics Company Details
Table 91. Advanced Cell Diagnostics Business Overview
Table 92. Advanced Cell Diagnostics RNA In Situ Hybridization Product
Table 93. Advanced Cell Diagnostics Revenue in RNA In Situ Hybridization Business (2018-2023) & (US$ Million)
Table 94. Advanced Cell Diagnostics Recent Developments
Table 95. Affymetrix Company Details
Table 96. Affymetrix Business Overview
Table 97. Affymetrix RNA In Situ Hybridization Product
Table 98. Affymetrix Revenue in RNA In Situ Hybridization Business (2018-2023) & (US$ Million)
Table 99. Affymetrix Recent Developments
Table 100. Exiqon Company Details
Table 101. Exiqon Business Overview
Table 102. Exiqon RNA In Situ Hybridization Product
Table 103. Exiqon Revenue in RNA In Situ Hybridization Business (2018-2023) & (US$ Million)
Table 104. Exiqon Recent Developments
Table 105. Agilent Technologies Company Details
Table 106. Agilent Technologies Business Overview
Table 107. Agilent Technologies RNA In Situ Hybridization Product
Table 108. Agilent Technologies Revenue in RNA In Situ Hybridization Business (2018-2023) & (US$ Million)
Table 109. Agilent Technologies Recent Developments
Table 110. Thermo Fisher Scientific Company Details
Table 111. Thermo Fisher Scientific Business Overview
Table 112. Thermo Fisher Scientific RNA In Situ Hybridization Product
Table 113. Thermo Fisher Scientific Revenue in RNA In Situ Hybridization Business (2018-2023) & (US$ Million)
Table 114. Thermo Fisher Scientific Recent Developments
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global RNA In Situ Hybridization Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global RNA In Situ Hybridization Market Share by Type: 2022 VS 2029
Figure 3. GISH Features
Figure 4. FISH Features
Figure 5. mFISH Features
Figure 6. PCR Features
Figure 7. Global RNA In Situ Hybridization Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global RNA In Situ Hybridization Market Share by Application: 2022 VS 2029
Figure 9. Hospitals Case Studies
Figure 10. Pharma & Biotech Companies Case Studies
Figure 11. Research Labs Case Studies
Figure 12. CROs Case Studies
Figure 13. RNA In Situ Hybridization Report Years Considered
Figure 14. Global RNA In Situ Hybridization Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global RNA In Situ Hybridization Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global RNA In Situ Hybridization Market Share by Region: 2022 VS 2029
Figure 17. Global RNA In Situ Hybridization Market Share by Players in 2022
Figure 18. Global Top RNA In Situ Hybridization Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA In Situ Hybridization as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by RNA In Situ Hybridization Revenue in 2022
Figure 20. North America RNA In Situ Hybridization Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America RNA In Situ Hybridization Market Share by Type (2018-2029)
Figure 22. North America RNA In Situ Hybridization Market Share by Application (2018-2029)
Figure 23. North America RNA In Situ Hybridization Market Share by Country (2018-2029)
Figure 24. United States RNA In Situ Hybridization Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada RNA In Situ Hybridization Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe RNA In Situ Hybridization Market Size YoY (2018-2029) & (US$ Million)
Figure 27. Europe RNA In Situ Hybridization Market Share by Type (2018-2029)
Figure 28. Europe RNA In Situ Hybridization Market Share by Application (2018-2029)
Figure 29. Europe RNA In Situ Hybridization Market Share by Country (2018-2029)
Figure 30. Germany RNA In Situ Hybridization Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France RNA In Situ Hybridization Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. RNA In Situ Hybridization Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy RNA In Situ Hybridization Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia RNA In Situ Hybridization Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Nordic Countries RNA In Situ Hybridization Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. China RNA In Situ Hybridization Market Size YoY (2018-2029) & (US$ Million)
Figure 37. China RNA In Situ Hybridization Market Share by Type (2018-2029)
Figure 38. China RNA In Situ Hybridization Market Share by Application (2018-2029)
Figure 39. Asia RNA In Situ Hybridization Market Size YoY (2018-2029) & (US$ Million)
Figure 40. Asia RNA In Situ Hybridization Market Share by Type (2018-2029)
Figure 41. Asia RNA In Situ Hybridization Market Share by Application (2018-2029)
Figure 42. Asia RNA In Situ Hybridization Market Share by Region (2018-2029)
Figure 43. Japan RNA In Situ Hybridization Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. South Korea RNA In Situ Hybridization Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. China Taiwan RNA In Situ Hybridization Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Southeast Asia RNA In Situ Hybridization Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. India RNA In Situ Hybridization Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Australia RNA In Situ Hybridization Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America RNA In Situ Hybridization Market Size YoY (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America RNA In Situ Hybridization Market Share by Type (2018-2029)
Figure 51. Middle East, Africa, and Latin America RNA In Situ Hybridization Market Share by Application (2018-2029)
Figure 52. Middle East, Africa, and Latin America RNA In Situ Hybridization Market Share by Country (2018-2029)
Figure 53. Brazil RNA In Situ Hybridization Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Mexico RNA In Situ Hybridization Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Turkey RNA In Situ Hybridization Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia RNA In Situ Hybridization Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Israel RNA In Situ Hybridization Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. GCC Countries RNA In Situ Hybridization Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Abbott Revenue Growth Rate in RNA In Situ Hybridization Business (2018-2023)
Figure 60. Biogenex Revenue Growth Rate in RNA In Situ Hybridization Business (2018-2023)
Figure 61. Biosb Revenue Growth Rate in RNA In Situ Hybridization Business (2018-2023)
Figure 62. Roche Revenue Growth Rate in RNA In Situ Hybridization Business (2018-2023)
Figure 63. Sigma-Aldrich Revenue Growth Rate in RNA In Situ Hybridization Business (2018-2023)
Figure 64. Advanced Cell Diagnostics Revenue Growth Rate in RNA In Situ Hybridization Business (2018-2023)
Figure 65. Affymetrix Revenue Growth Rate in RNA In Situ Hybridization Business (2018-2023)
Figure 66. Exiqon Revenue Growth Rate in RNA In Situ Hybridization Business (2018-2023)
Figure 67. Agilent Technologies Revenue Growth Rate in RNA In Situ Hybridization Business (2018-2023)
Figure 68. Thermo Fisher Scientific Revenue Growth Rate in RNA In Situ Hybridization Business (2018-2023)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
  • Global Targeted RNA Sequencing Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 71
    Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing The ability to detect both known and novel gene fusion partners in many sample types. In The report, we ......
  • Global Targeted RNA Sequencing Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 87
    According to our LPI (LP Information) latest study, the global Targeted RNA Sequencing market size was valued at US$ 1761.4 million in 2023. With growing demand in downstream market, the Targeted RNA Sequencing is forecast to a readjusted size of US$ 7649.2 million by 2030 with a CAGR of 23.3% during review period. The research report highlights the growth potential of the global Targeted RNA Sequencing market. Targeted RNA Sequencing are expected to show stable growth in the future mark......
  • Global Targeted RNA Sequencing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 94
    According to our (Global Info Research) latest study, the global Targeted RNA Sequencing market size was valued at USD 1852.7 million in 2023 and is forecast to a readjusted size of USD 7255.4 million by 2030 with a CAGR of 21.5% during review period. Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or ......
  • Global Antisense and RNAi Therapeutics Market Research Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 2680 Onwards        Pages: 133
    Antisense therapy means the selective, sequence-specific inhibition of gene expression by single-stranded DNA oligonucleotides. In contrast, RNA interference (RNAi) is triggered by double-stranded RNA (dsRNA) and causes sequence-specific mRNA degradation of single-stranded target RNAs in response to dsRNA. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (millio......
  • Global Antisense and RNAi Therapeutics Professional Survey Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 101
    Antisense therapy means the selective, sequence-specific inhibition of gene expression by single-stranded DNA oligonucleotides. In contrast, RNA interference (RNAi) is triggered by double-stranded RNA (dsRNA) and causes sequence-specific mRNA degradation of single-stranded target RNAs in response to dsRNA. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (millio......
  • Global Targeted RNA Sequencing Market Research Report 2023, Forecast to 2028
    Published: 13-Nov-2023        Price: US 2680 Onwards        Pages: 137
    Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......
  • Global Targeted RNA Sequencing Professional Survey Report 2023, Forecast to 2028
    Published: 13-Nov-2023        Price: US 3280 Onwards        Pages: 100
    Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......
  • Global RNAi for Therapeutic Market Status and Outlook 2023-2028
    Published: 08-Nov-2023        Price: US 3160 Onwards        Pages: 106
    RNAi is a fundamental cellular mechanism for silencing gene expression that can be harnessed for the development of new drugs Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......
  • Global RNAi for Therapeutic Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 24-Oct-2023        Price: US 3380 Onwards        Pages: 104
    Market Overview of Global RNAi for Therapeutic market: According to our latest research, the global RNAi for Therapeutic market looks promising in the next 5 years. As of 2022, the global RNAi for Therapeutic market was estimated at USD 260.55 million, and it's anticipated to reach USD 3633.33 million in 2028, with a CAGR of 55.14% during the forecast years. RNA interference (RNAi) is a collection of small RNA directed mechanisms that result in sequence specific inhibition of......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs